Radiotherapy: Difference between revisions

From Citizendium
Jump to navigation Jump to search
imported>Robert Badgett
imported>Robert Badgett
Line 16: Line 16:
Radiotherapy can be classified by delivery methods:
Radiotherapy can be classified by delivery methods:
* External beam
* External beam
* Brachytherapy is "A collective term for interstitial, intracavity, and surface rgb(255, 255, 204);">radiotherapy. It uses small sealed or partly-sealed sources that may be placed on or near the body surface or within a natural body cavity or implanted directly into the tissues."<ref name="MeSH-Brachytherapy">{{cite web |url=http://www.nlm.nih.gov/cgi/mesh/2008/MB_cgi?term=Brachytherapy |title=Brachytherapy |author=National Library of Medicine |accessdate=2007-12-26 |format= |work=}}</ref>
* Brachytherapy is "a collective term for interstitial, intracavity, and surface radiotherapy. It uses small sealed or partly-sealed sources that may be placed on or near the body surface or within a natural body cavity or implanted directly into the tissues."<ref name="MeSH-Brachytherapy">{{cite web |url=http://www.nlm.nih.gov/cgi/mesh/2008/MB_cgi?term=Brachytherapy |title=Brachytherapy |author=National Library of Medicine |accessdate=2007-12-26 |format= |work=}}</ref>
* Radioimmunotherapy is Radiotherapy where cytotoxic radionuclides are linked to antibodies in order to deliver toxins directly to tumor targets. Therapy with targeted radiation rather than antibody-targeted toxins (immunotoxins) has the advantage that adjacent tumor cells, which lack the appropriate antigenic determinants, can be destroyed by radiation cross-fire. Radioimmunotherapy is sometimes called targeted radiotherapy, but this latter term can also refer to radionuclides linked to non-immune molecules."<ref name="MeSH-Radioimmunotherapy">{{cite web |url=http://www.nlm.nih.gov/cgi/mesh/2008/MB_cgi?term=Radioimmunotherapy |title=Radioimmunotherapy |author=National Library of Medicine |accessdate=2007-12-26 |format= |work=}}</ref>
* Radioimmunotherapy is "radiotherapy where cytotoxic radionuclides are linked to antibodies in order to deliver toxins directly to tumor targets. Therapy with targeted radiation rather than antibody-targeted toxins (immunotoxins) has the advantage that adjacent tumor cells, which lack the appropriate antigenic determinants, can be destroyed by radiation cross-fire. Radioimmunotherapy is sometimes called targeted radiotherapy, but this latter term can also refer to radionuclides linked to non-immune molecules."<ref name="MeSH-Radioimmunotherapy">{{cite web |url=http://www.nlm.nih.gov/cgi/mesh/2008/MB_cgi?term=Radioimmunotherapy |title=Radioimmunotherapy |author=National Library of Medicine |accessdate=2007-12-26 |format= |work=}}</ref>


Radiotherapy can be classified by the target of the therapy:
Radiotherapy can be classified by the target of the therapy:
* Hemibody Irradiation
* Hemibody Irradiation
* Whole-Body Irradiation
* Whole-body Irradiation
* Lymphatic Irradiation
* Lymphatic Irradiation



Revision as of 09:48, 26 December 2007

Radiotherapy is "the use of ionizing radiation to treat malignant neoplasms and some benign conditions."[1][2]

Classification

Radiotherapy can be classified by type of radiation, which includes:

  • Electromagnetic (photons)
    • X-Ray
    • Gamma ray
  • Electrons. Electrons are used for superficial targets as the energy of electrons decreases during penetration of tissues
  • Protons. Initial research suggests that proton beams with conformal methods, can increase the accuracy of placement of the radiation. A randomized controlled trial of radiotherapy for prostate cancer found improved response of prostate specific antigen without increased local complications.[3] There is concern that particle accelerators for producing protons are proliferating in American health care prior to adequate study of the their role.[4]

Radiotherapy can be classified by the amount of energy associated with the radiation:

  • High-energy radiotherapy is "radiotherapy using high-energy (megavolt or higher) ionizing radiation. Types of radiation include gamma rays, produced by a radioisotope within a teletherapy unit; x-rays, electrons, protons, alpha particles (helium ions) and heavy charged ions, produced by particle acceleration; and neutrons and pi-mesons (pions), produced as secondary particles following bombardment of a target with a primary particle."[5]
  • Orthovoltage therapy is x-rays between 150 and 500 kV
  • Lower energy x-rays (50 to 150 kV) can be used for superficial therapy.

Radiotherapy can be classified by delivery methods:

  • External beam
  • Brachytherapy is "a collective term for interstitial, intracavity, and surface radiotherapy. It uses small sealed or partly-sealed sources that may be placed on or near the body surface or within a natural body cavity or implanted directly into the tissues."[6]
  • Radioimmunotherapy is "radiotherapy where cytotoxic radionuclides are linked to antibodies in order to deliver toxins directly to tumor targets. Therapy with targeted radiation rather than antibody-targeted toxins (immunotoxins) has the advantage that adjacent tumor cells, which lack the appropriate antigenic determinants, can be destroyed by radiation cross-fire. Radioimmunotherapy is sometimes called targeted radiotherapy, but this latter term can also refer to radionuclides linked to non-immune molecules."[7]

Radiotherapy can be classified by the target of the therapy:

  • Hemibody Irradiation
  • Whole-body Irradiation
  • Lymphatic Irradiation

Computer-assisted radiotherapy

Computer-assisted radiotherapy is the use of "computer systems or programs used in accurate computations for providing radiation dosage treatment to patients."[8] Methods of computer-assisted radiotherapy include:

  • Conformal photon-beam therapy
  • Intensity-modulated radiation

References

  1. National Library of Medicine. Radiotherapy. Retrieved on 2007-12-26.
  2. Symonds RP (2001). "Recent advances: Radiotherapy". BMJ 323 (7321): 1107–10. PMID 11701579[e] Fulltext at PubMed Central
  3. Zietman AL, DeSilvio ML, Slater JD, et al (2005). "Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: a randomized controlled trial". JAMA 294 (10): 1233–9. DOI:10.1001/jama.294.10.1233. PMID 16160131. Research Blogging.
  4. Pollack, Andrew (2007). Hospitals Look to Nuclear Tool to Fight Cancer - New York Times. New York Times. Retrieved on 2007-12-26.
  5. National Library of Medicine. High-Energy radiotherapy. Retrieved on 2007-12-26.
  6. National Library of Medicine. Brachytherapy. Retrieved on 2007-12-26.
  7. National Library of Medicine. Radioimmunotherapy. Retrieved on 2007-12-26.
  8. National Library of Medicine. Computer-assisted radiotherapy. Retrieved on 2007-12-26.